Epiomic Epidemiology Series: Addison's Disease Forecast in 10 Major Markets 2016-2026
Addison's disease is a chronic and rare endocrinal disorder, caused by destruction of the adrenal cortex which leads to the reduced production of glucocorticoids, mineralocorticoids and adrenal androgens. Chronic adrenal insufficiency and hypersecretion of adrenocorticotropic hormone (ACTH) is representative of the basic clinical signs and symptoms.
This report provides the current prevalent population for Addison’s disease across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India and Poland) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Addison’s disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Addison’s disease include:
Reason to buy
This report provides the current prevalent population for Addison’s disease across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India and Poland) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Addison’s disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Addison’s disease include:
- Autoimmune thyroiditis
- Type 1 diabetes
- Anaemia
- Vitiligo
- Chronic fatigue
- Premature ovarian failure
- Hypopigmentation
Reason to buy
- Able to quantify patient populations in global Addison’s disease’s market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the prevalence of the subdivided types of Addison’s disease and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Provide a level of understanding on the impact from specific co-morbid conditions on Addison’s disease’s prevalent population.
- Identify sub-populations within Addison’s disease which require treatment.
- Gain an understanding of the specific markets that have the largest number of Addison’s disease patients.
Introduction
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/ Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Prevalence for Addison’s Disease
Main Complications and Features of Addison’s Disease Patients
Classification of Addison’s Disease
Number of concomitant conditions in Addison’s Disease
Co-morbidities within Addison’s disease
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
Cause of the Disease
Risk Factors & Prevention
Diagnosis of the Disease
Variation by Geography/Ethnicity
Disease Prognosis & Clinical Course
Key Co-morbid Conditions/ Features Associated with the Disease
Methodology for Quantification of Patient Numbers
Top-Line Prevalence for Addison’s Disease
Main Complications and Features of Addison’s Disease Patients
Classification of Addison’s Disease
Number of concomitant conditions in Addison’s Disease
Co-morbidities within Addison’s disease
Abbreviations used in the Report
Other Black Swan Analysis Publications
Black Swan Analysis Online Patient-Based Databases
Patient-Based Offering
Online Pricing Data and Platforms
References
Appendix
LIST OF TABLES & FIGURES
Prevalence of Addison’s, total (000s)
Prevalence of Addison’s, males (000s)
Prevalence of Addison’s, females (000s)
Addison’s patients by type, total (000s)
Addison’s patients by number of concomitant conditions, total (000s)
Addison’s patients with Autoimmune Thyroiditis (AT), total (000s)
Addison’s patients with T1D, total (000s)
Addison’s patients with Chronic Fatigue, total (000s)
Addison’s patients with Anaemia, total (000s)
Addison’s patients with Vitiligo, total (000s)
Abbreviations and Acronyms used in the Report
USA Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
USA Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
France Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
France Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Germany Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Germany Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Italy Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Italy Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Spain Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Spain Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
United Kingdom Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
United Kingdom Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Brazil Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Brazil Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Japan Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Japan Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
India Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
India Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Prevalence of Addison’s, total (000s)
Prevalence of Addison’s, males (000s)
Prevalence of Addison’s, females (000s)
Addison’s patients by type, total (000s)
Addison’s patients by number of concomitant conditions, total (000s)
Addison’s patients with Autoimmune Thyroiditis (AT), total (000s)
Addison’s patients with T1D, total (000s)
Addison’s patients with Chronic Fatigue, total (000s)
Addison’s patients with Anaemia, total (000s)
Addison’s patients with Vitiligo, total (000s)
Abbreviations and Acronyms used in the Report
USA Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
USA Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
France Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
France Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Germany Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Germany Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Italy Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Italy Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Spain Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Spain Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
United Kingdom Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
United Kingdom Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Brazil Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Brazil Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
Japan Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
Japan Prevalence of Addison’s disease by 5-yr age cohort, females (000s)
India Prevalence of Addison’s disease by 5-yr age cohort, males (000s)
India Prevalence of Addison’s disease by 5-yr age cohort, females (000s)